The limited impact of CYP3A5 genotype for the pharmacokinetics of CYP3A substrates Oliver BurkMatthias Schwab Editorial Commentary 12 October 2007 Pages: 1097 - 1098
Antibiotic prescription and prevalence rate in the outpatient paediatric population: analysis of surveys published during 2000–2005 Alessandra RossignoliAntonio ClavennaMaurizio Bonati Review Article 21 September 2007 Pages: 1099 - 1106
Oxidative stress and endothelium influenced by metformin in type 2 diabetes mellitus Jan ŠkrhaMartin PráznýTomáš Zima Clinical Trial 15 September 2007 Pages: 1107 - 1114
Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana Reinout VriesendorpAdam CohenJacobus Stiekema Clinical Trial Open access 20 September 2007 Pages: 1115 - 1121
Pupillography as a sensitive, noninvasive biomarker in healthy volunteers: first-in-man study of BAY 63–9044, a new 5-HT1A-receptor agonist with dopamine agonistic properties Georg WensingClaus HaaseMichael Friedrich Böttcher Pharmacodynamics 25 September 2007 Pages: 1123 - 1128
Impact of the CYP3A5 genotype on midazolam pharmacokinetics and pharmacodynamics during intensive care sedation Martin F. FrommHelmut SchwildenJürgen Schüttler Pharmacogenetics 05 September 2007 Pages: 1129 - 1133
Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients Liyan MiaoJian YangZhenya Shen Pharmacogenetics 27 September 2007 Pages: 1135 - 1141
Haemodialysis clearance of baclofen Miran BrvarMatjaž VrtovecMatjaz Bunc Pharmacokinetics and Disposition 02 September 2007 Pages: 1143 - 1146
Impact of the CYP2D6 genotype on steady-state serum concentrations of aripiprazole and dehydroaripiprazole Magnhild HendsetMonica HermannEspen Molden Pharmacokinetics and Disposition 09 September 2007 Pages: 1147 - 1151
Population pharmacokinetics of buprenorphine following a two-stage intravenous infusion in healthy volunteers Mette L. JensenDavid J. R. FosterLona Christrup Pharmacokinetics and Disposition 16 September 2007 Pages: 1153 - 1159
Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients Masatomo MiuraShigeru SatohTomonori Habuchi Pharmacokinetics and Disposition 29 September 2007 Pages: 1161 - 1169
How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning? Martina TeichertAngelie van der AalstPeter A. G. M. De Smet Pharmacoepidemiology and Prescription Open access 02 October 2007 Pages: 1171 - 1177
Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring Valérie SantschiGrégoire WuerznerMichel Burnier Pharmacoepidemiology and Prescription 25 September 2007 Pages: 1179 - 1184
Detection and prevention of prescriptions with excessive doses in electronic prescribing systems H. M. SeidlingA. Al BarmawiW. E. Haefeli Pharmacoepidemiology and Prescription 05 September 2007 Pages: 1185 - 1192
Evaluation of patients’ experiences with antidepressants reported by means of a medicine reporting system E. C. G. van GeffenS. W. van der WalE. R. Heerdink Pharmacoepidemiology and Prescription Open access 15 September 2007 Pages: 1193 - 1199
Appropriateness of serum digoxin levels Giuseppe LippiGian Luca SalvagnoGian Cesare Guidi Letter to the Editors 16 September 2007 Pages: 1201 - 1202
Tablet splitting: patients and physicians need better support R. QuinzlerJ. SzecsenyiW. E. Haefeli Letter to the Editors 25 September 2007 Pages: 1203 - 1204